Discontinued operations - General (Details) $ in Millions |
12 Months Ended | 24 Months Ended | ||
|---|---|---|---|---|
|
Apr. 02, 2024
USD ($)
|
Apr. 02, 2024
CHF (SFr)
|
Dec. 31, 2024
CHF (SFr)
|
Dec. 31, 2025
CHF (SFr)
|
|
| Neurosterix Pharma Sarl | ||||
| Disclosure | ||||
| Amount of committed funding received in million | $ | $ 65 | |||
| Neurosterix US Holdings LLC | ||||
| Disclosure | ||||
| Percentage of equity interest received | 20.00% | 20.00% | ||
| Discontinued operations as disclosed below | ||||
| Disclosure | ||||
| Gross proceeds in cash received from Neurosterix Transaction | SFr | SFr 5,000,000 | SFr 5,000,000 | SFr 5,000,000 | |
| Discontinued operations as disclosed below | Neurosterix US Holdings LLC | ||||
| Disclosure | ||||
| Percentage of equity interest received | 20.00% | 20.00% | 20.00% | |